Publications & Congress September 15, 2023 Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
Publications & Congress June 28, 2023 ISTH 2023 Oral Presentation: Patient-Relevant Bleeding Events Among Patients Taking Anticoagulant Medication
Publications & Congress November 15, 2022 Exploring Factor XI: A Paradigm Shift Towards Hemostasis-Sparing Anticoagulation
Publications & Congress November 02, 2022 Management of Thrombosis in High-Risk Patients: Focus on Cancer Associated Thrombosis
Publications & Congress December 09, 2021 Factor XI Inhibition: The Holy Grail of Hemostasis‐ Sparing Anticoagulation
Publications & Congress September 03, 2021 Factor XI Inhibition to Uncouple Thrombosis From Hemostasis – JACC 2021
Publications & Congress July 07, 2021 Anthos: Solving the thrombosis dilemma with a hemostasis-sparing anticoagulant – Nature 2020
Publications & Congress July 06, 2021 MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans. Blood 2019